QUANTRX BIOMEDICAL CORP - FORM 10-Q - EX-32 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER REQUIRED UNDER RULE 13A-14(A) OR RULE 15D-14(A) OF THE SECURITIES AND EXCHANGE ACT OF 1934, AS AMENDED, AND 18 U.S.C. SECTION 1350. - July 22, 2015

Attached files

file filename
10-Q - 10-Q - QUANTRX BIOMEDICAL CORPqtxb10qmar312015.htm
EX-10.1 - FORM OF BRIDGE NOTE - QUANTRX BIOMEDICAL CORPex10-1.htm
EX-31 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER REQUIRED UNDER RULE 13A-14(A) OR RULE 15D-14(A) OF THE SECURITIES AND EXCHANGE ACT OF 1934, AS AMENDED. - QUANTRX BIOMEDICAL CORPex31.htm
XML - IDEA: XBRL DOCUMENT - QUANTRX BIOMEDICAL CORPR9999.htm
Exhibit 32

CERTIFICATION PURSUANT TO 18 U.S.C. §1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the accompanying Quarterly Report of QuantRx Biomedical Corporation (the "Company") on Form 10-Q for the period ending March 31, 2015, as filed with the Securities and Exchange Commission on or about the date hereof (the "Report"), the undersigned, Shalom Hirschman, Principal Executive and Principal Financial and Accounting Officer of the Company, certifies, to my best knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
Date: July 22, 2015
/s/ Shalom Hirschman
 
Shalom Hirschman
Principal Executive and Financial Officer
 

QUANTRX BIOMEDICAL CORP Reports